{"result": {"id": "chatcmpl-311", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **CCK-8 ASSAY** is a method used to measure both cell proliferation and cell viability. It can also be used to assess the pro-angiogenic potential of ocular endothelial cells (OECs) in vitro.  This assay measures the ability of cells to grow and survive, providing insights into their proliferative capacity and overall health. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743161811, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 73, "prompt_tokens": 218, "total_tokens": 291, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"CCK-8 ASSAY\"\nDescription List: [\"The **CCK-8 ASSAY** is a method used to measure cell viability and proliferation.  It can also be used to assess the pro-angiogenic potential of ocular endothelial cells (OECs) in vitro. \\n\", \"The **CCK-8 ASSAY** is an assay used to measure both cell proliferation and cell viability. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_333d3e79171bf6c5298d1380cacfa5e304fa044fa07fbac4d3067bc5cb733c51_v2"}